| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CTD-2278I10.6 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | ZBED6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | C7orf55-LUC7L2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | DOT1L | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | TMEM236 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | C17orf67 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | LRRCC1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | TNFAIP8L2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | EFCAB5 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | RP11-58C22.1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
